Epidemiological Studies Using Biological Markers: Issues for Epidemiologists1

نویسندگان

  • Barbara S. Hulka
  • Barbara Hulka
چکیده

On April 1 1, 199 1, Barbara Sorenson Hulka, M.D., MPH., received the Distinguished Achievement Award of the American Society of Preventive Oncology (ASPO) at the annual meeting of the Society in Seattle, Washington. The award is given by the Executive Committee of ASPO in recognition of contributions to the prevention of cancer over many years, not for a single accomplishment. Any member of ASPO may nominate a candidate for the award. The 15-member Executive Committee votes by secret ballot after considering a summary of the contributions to cancer prevention of the several candidates. Dr. Hulka won in a close election over several other outstanding scientists. Dr. Hulka has chaired the Department of Epidemiology at the University of North Carolina School of Public Health since 1983. During her tenure she has developed the Epidemiology Department into one of the best in the country. The basis for her award, however, was her 25 years of work in the prevention of cancers of female reproductive organs. Dr. Hulka began her career with a series of critical studies of cervical cancer in underserved populations. These were followed by studies of the role of hormones in endometrial and breast cancers, a field in which she continues to make important contributions. She has brought to these studies a balanced evaluation of the risks and benefits of hormones rarely found in epidemiological research. Dr. Hulka has been incredibly generous in her service on state and national advisory committees. Since 1973 she has served on 26 national advisory committees, been a member of the editorial boards of seven journals, and been a consultant to numerous public and private organizations. Dr. Hulka is a graduate of Radcliffe College, the Julliard School of Music, and Columbia University’s College ofPhysicians and Surgeons and received her MPH. from Columbia University SchoolofPublic Health. It was an honor for ASPO to bestow its Distinguished Achievement Award on Barbara Hulka.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

ASPO Distinguished Achievement Award Lecture Epidemiological Studies Using Biological Markers: Issues for Epidemiologists1

On April 1 1, 199 1, Barbara Sorenson Hulka, M.D., MPH., received the Distinguished Achievement Award of the American Society of Preventive Oncology (ASPO) at the annual meeting of the Society in Seattle, Washington. The award is given by the Executive Committee of ASPO in recognition of contributions to the prevention of cancer over many years, not for a single accomplishment. Any member of AS...

متن کامل

Design and analysis issues in gene and environment studies

Both nurture (environmental) and nature (genetic factors) play an important role in human disease etiology. Traditionally, these effects have been thought of as independent. This perspective is ill informed for non-mendelian complex disorders which result as an interaction between genetics and environment. To understand health and disease we must study how nature and nurture interact. Recent ad...

متن کامل

Psychiatric epidemiology in Turkey: main advances in recent studies and future directions.

OBJECTIVE To overview and evaluate the main findings, methodological shortcomings, and time trends of the recent psychiatric epidemiology studies in Turkey, as well as to provide areas prone for development in forthcoming research. METHOD PubMed and Turkish Psychiatry Index were screened to identify relevant studies. Any epidemiological study from 2000 to 2012 with a general population or uni...

متن کامل

Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement.

Molecular data are now widely used in epidemiological studies to investigate the transmission, distribution, biology, and diversity of pathogens. Our objective was to establish recommendations to support good scientific reporting of molecular epidemiological studies to encourage authors to consider specific threats to valid inference. The statement Strengthening the Reporting of Molecular Epide...

متن کامل

Design of Early Validation Trials of Biomarkers

The design of early-phase studies of putative screening markers in clinical populations is discussed. Biological, epidemiological, statistical and computational issues all affect the design of early-phase studies of these markers, but there are frequently little or no data in hand to facilitate the design. Early-phase studies must be designed as part of a development program, considering the fi...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2005